BCL2 and prostate carcinoma: Overexpression of anti-apoptotic proteins (e.g., Bcl-2, Bcl-xL, Mcl-1) is a common hallmark across various cancers, often exhibiting distinct patterns of expression in different cancer types such as breast, gastric, lung, and prostate cancers [24] (Table 1).